CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right to Buy) | +3,318 | 3,318 | ||
| 2026-06-09 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +19,909 | 19,909 | ||
| 2026-06-09 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +2,323 | 2,323 | ||
| 2026-06-09 | Phillips Gary M. Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | Phillips Gary M. Director | Grant or award · Stock Option (Right to Buy) | +6,636 | 6,636 | ||
| 2026-06-09 | Phillips Gary M. Director | Grant or award · Stock Option (Right to Buy) | +4,977 | 4,977 | ||
| 2026-06-09 | Clark William D Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | Clark William D Director | Grant or award · Stock Option (Right to Buy) | +2,323 | 2,323 | ||
| 2026-06-09 | Walker Neal Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | Walker Neal Director | Grant or award · Stock Option (Right to Buy) | +3,318 | 3,318 | ||
| 2026-06-09 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +5,309 | 5,309 | ||
| 2026-06-09 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +4,977 | 4,977 | ||
| 2026-06-09 | DEPTULA-HICKS DARLENE M Director | Grant or award · Stock Option (Right to Buy) | +84,557 | 84,557 | ||
| 2026-06-09 | DEPTULA-HICKS DARLENE M Director | Grant or award · Stock Option (Right to Buy) | +9,756 | 9,756 | ||
| 2026-06-03 | Brady Todd C President and CEO | Purchase | +250,000 | $1.67 | $418K | 1,721,298 |
| 2026-03-27 | Brady Todd C President and CEO | Grant or award · Stock Option (right to buy) | +1,880,510 | 1,880,510 | ||
| 2026-03-27 | Brady Todd C President and CEO | Grant or award · Bonus Units | +632,318 | 632,318 |
Page 1 of 19 · 376 trades